MEGAN TARATUTA: Open Payments
NPI 1619119393 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 31 payments from 14 companies in 2025. Trend: 2023 $1,315 · 2024 $1,077 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $210 |
| Novartis Pharmaceuticals Corporation | 7 | $124 |
| Boston Scientific Corporation | 3 | $69 |
| Alnylam Pharmaceuticals Inc. | 3 | $54 |
| PFIZER INC. | 2 | $38 |
| CARDIVA MEDICAL, INC. | 1 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| BridgeBio Pharma, Inc. | 1 | $23 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
Products named: MOUNJARO, LEQVIO, WATCHMAN FLX, ONPATTRO, VYNDAQEL, OPTOWIRE, JARDIANCE, Attruby.
Industry payments across MI — which companies pay providers there.
